,
your personalized virtual assistant to find clinical trials. Go head, 
George Kovach, MD
Genesis Regional Cancer Center at ...Davenport, Iowa - 52803 (563-421-1960) Genesis Medical Center - West ...Davenport, Iowa - 52804 (563-421-1960) |
- CLINICAL TRIALS 25
- CONDITIONS40
- INTERVENTIONS57
- SINCE1989
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer
July 2008 - August 2009
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
March 2005 - June 2015
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -
Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
February 1989 -
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
March 1993 -
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
November 2008 - August 2009
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
March 2007 - November 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Myelodysplastic Syndromes
Preleukemia
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Fatigue
Carcinoma, Non-Small-Cell Lung
Bone Neoplasms
Bone Marrow Diseases
Carcinoma, Small Cell
Neurotoxicity Syndromes
Precancerous Conditions
Myeloproliferative Disorders
Colorectal Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Neuroendocrine Tumors
Hematologic Neoplasms
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Waldenstrom Macroglobulinemia
Osteonecrosis
Carcinoma, Neuroendocrine
Monoclonal Gammopathies, Benign
Paraproteinemias
Placebo
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Zoledronic Acid
Celecoxib
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Aflibercept
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Dasatinib
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Capecitabine
Oxaliplatin
Doxorubicin Hydrochloride
Temsirolimus
Polymerase Chain Reaction
Goserelin
Leuprolide Acetate
Trastuzumab
Lapatinib Ditosylate
Cixutumumab
Sorafenib Tosylate
Thalidomide
Fluorescence In Situ Hybridization
Conventional Surgery
Mutation Analysis
Cetuximab
Biologic Sample Preservation Procedure
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Ac Regimen
Cytogenetic Analysis
Vinorelbine Ditartrate
Recombinant Interferon Alfa-2b
Octreotide Acetate
Acetyl-L-Carnitine Hydrochloride
Cryopreservation
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
Active Surveillance
